# Observational Study of Obstructive Lung Disease (NOVELTY)

> **NCT02760329** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 12255 (actual)

## Conditions studied

- Asthma
- COPD
- Chronic Obstructive Pulmonary Disease

## Interventions

- **PROCEDURE:** Blood draw
- **PROCEDURE:** Urine
- **PROCEDURE:** Lung function measurements
- **PROCEDURE:** Fractional Exhaled Nitric Oxide (FENO)

## Key facts

- **NCT ID:** NCT02760329
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-25
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 12255 (ACTUAL)
- **Last updated:** 2024-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02760329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02760329, "Observational Study of Obstructive Lung Disease (NOVELTY)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02760329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*